Work

Case Report: Primary hyperoxaluria type 1 with a previously unreported deep intronic AGXT variant

Year: 2026
Type: article
Study design: Case Report
Abstract: We report a patient on maintenance hemodialysis who presented with systemic oxalosis manifesting as shrunken hyperdense kidneys, diffusely increased bone density, soft-tissue calcifications, and refractory hypoalbuminemia. Whole-exome sequencing (WES) identified only one pathogenic allele, a heterozygous frameshift duplication in AGXT , c.823_824dupAG (p.Ser275Argfs*38). Subsequent whole-genome sequencing (WGS) revealed a previously unreported deep intronic variant c.525-158C>T in AGXT intron 4, classified as likely pathogenic according to the ACMG/AMP guidelines. This compound heterozygosity, together with the characteristic clinical and histological features, supports a clinical diagnosis of primary hyperoxaluria type 1 (PH1). According to the patient’s own report, numbness and pain in the extremities were substantially relieved following two successive sodium thiosulfate (STS) administration regimens, with concomitant high-dose pyridoxine and intensified high-flux hemodialysis. This case highlights the diagnostic delay of PH1 in adults with unexplained kidney failure and the ascertainment gap of exome-based testing for deep intronic splice-altering variants, and supports pursuing WGS when clinical suspicion persists despite inconclusive WES. In addition, the role of STS in the management of PH1 may merit further investigation.
Language: English
Subfield: Urology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233802595
FWCI:
Cites: 17
Cited by:
Related to: 10
Parts: 2